GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (FRA:MFJ) » Definitions » Other Stockholders Equity

Polynovo (FRA:MFJ) Other Stockholders Equity : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Polynovo Other Stockholders Equity?

Polynovo's Other Stockholders Equity for the quarter that ended in Jun. 2024 was €0.00 Mil.

Polynovo's quarterly Other Stockholders Equity increased from Jun. 2023 (€-0.00 Mil) to Dec. 2023 (€-0.00 Mil) and increased from Dec. 2023 (€-0.00 Mil) to Jun. 2024 (€0.00 Mil).

Polynovo's annual Other Stockholders Equity declined from Jun. 2022 (€0.00 Mil) to Jun. 2023 (€-0.00 Mil) but then increased from Jun. 2023 (€-0.00 Mil) to Jun. 2024 (€0.00 Mil).

Polynovo Other Stockholders Equity Historical Data

The historical data trend for Polynovo's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Other Stockholders Equity Chart

Polynovo Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Polynovo Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Polynovo Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Polynovo Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Polynovo's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Polynovo Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (FRA:MFJ) » Definitions » Other Stockholders Equity
Comparable Companies
ASX:IMR ASX:ARX ASX:AVR ASX:4DX ASX:EMV ASX:CYC ASX:IPD ASX:RSH ASX:NTI ASX:SOM ABT SYK BSX MDT XTER:SHL SZSE:300760 EW DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
CALZF:USA PNV:Australia
Address
320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Website
https://www.polynovo.com
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo Headlines

No Headlines